Recurrent Stroke Prevention Clinical Outcome Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5000 participants.

Also called NCT01198496

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 5,000 participants (planned count) (from the registry)
Sponsor
Biomedis International Ltd. (from the registry)
Registry
  • NCT NCT01198496
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01198496. Randomized; no masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Recurrent Stroke Prevention Clinical Outcome Study
Acronym
RESPECTS
Condition
Hypertension
Condition
Stroke
Condition
Blood Pressure
Intervention (Drug)
Losartan, Losartan and HCTZ, Amlodipine , Spironolactone
Lead sponsor
Biomedis International Ltd. (class: other)

Record details

Record id
cardio:ct-nct01198496
Content hash
c2e60a8fc31a89f69e731e8fd9fd7770b86ca6989b94c2537dafaaff8fda1610